Insufficient scRNA-seq data for expression of GAL3ST2 at single-cell level.
Insufficient scRNA-seq data for expression of GAL3ST2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 75% | 8.43 | 135 / 180 | 92% | 12.43 | 394 / 430 |
intestine | 79% | 128.41 | 759 / 966 | 84% | 14.27 | 441 / 527 |
brain | 91% | 14.56 | 2409 / 2642 | 44% | 0.88 | 310 / 705 |
stomach | 36% | 2.53 | 130 / 359 | 73% | 11.13 | 208 / 286 |
bladder | 76% | 7.43 | 16 / 21 | 27% | 4.02 | 137 / 504 |
esophagus | 46% | 3.29 | 670 / 1445 | 54% | 7.69 | 99 / 183 |
adrenal gland | 77% | 23.80 | 198 / 258 | 20% | 0.59 | 46 / 230 |
liver | 83% | 18.84 | 187 / 226 | 11% | 0.30 | 46 / 406 |
prostate | 85% | 14.52 | 208 / 245 | 9% | 0.18 | 45 / 502 |
uterus | 69% | 8.66 | 118 / 170 | 24% | 1.45 | 110 / 459 |
kidney | 90% | 17.87 | 80 / 89 | 3% | 0.08 | 27 / 901 |
breast | 55% | 4.90 | 254 / 459 | 30% | 1.99 | 336 / 1118 |
lung | 57% | 5.36 | 331 / 578 | 27% | 1.43 | 313 / 1155 |
thymus | 67% | 6.05 | 437 / 653 | 5% | 0.18 | 31 / 605 |
adipose | 68% | 20.13 | 817 / 1204 | 0% | 0 | 0 / 0 |
skin | 62% | 5.19 | 1118 / 1809 | 3% | 0.06 | 13 / 472 |
muscle | 61% | 5.32 | 491 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 50% | 3.65 | 671 / 1335 | 0% | 0 | 0 / 0 |
spleen | 46% | 2.99 | 112 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 43% | 6.15 | 397 / 929 | 0% | 0 | 0 / 0 |
heart | 42% | 3.58 | 362 / 861 | 0% | 0 | 0 / 0 |
pancreas | 23% | 1.11 | 74 / 328 | 14% | 0.69 | 25 / 178 |
tonsil | 0% | 0 | 0 / 0 | 18% | 0.82 | 8 / 45 |
lymph node | 0% | 0 | 0 / 0 | 10% | 0.39 | 3 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0009101 | Biological process | glycoprotein biosynthetic process |
GO_0008150 | Biological process | biological_process |
GO_0009247 | Biological process | glycolipid biosynthetic process |
GO_0032580 | Cellular component | Golgi cisterna membrane |
GO_0016020 | Cellular component | membrane |
GO_0008146 | Molecular function | sulfotransferase activity |
GO_0001733 | Molecular function | galactosylceramide sulfotransferase activity |
GO_0005515 | Molecular function | protein binding |
GO_0050694 | Molecular function | galactose 3-O-sulfotransferase activity |
Gene name | GAL3ST2 |
Protein name | Galactose-3-O-sulfotransferase 2 Galactose-3-O-sulfotransferase 2 (Gal3ST-2) (EC 2.8.2.-) (Beta-galactose-3-O-sulfotransferase 2) (Gal-beta-1, 3-GalNAc 3'-sulfotransferase 2) (Glycoprotein beta-Gal 3'-sulfotransferase 2) |
Synonyms | GP3ST |
Description | FUNCTION: Transfers a sulfate group to the hydroxyl group at C3 of non-reducing beta-galactosyl residues. Acts both on type 1 (Gal-beta-1,3-GlcNAc) and type 2 (Gal-beta-1,4-GlcNAc) chains with similar efficiency. |
Accessions | A0A0J9YWU2 ENST00000192314.7 ENST00000632847.1 Q9H3Q3 A0A0G2JPZ6 ENST00000610560.3 |